IP Library Granted Patent US 8,288,570
Granted Patent B2
US 8,288,570 · App. 13/031,075 · Granted Oct 16, 2012

7-iodo tetracyclines and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,288,570
App. No.
13/031,075
Granted
Oct 16, 2012
Kind
B2
Abstract

7-substituted fused ring tetracycline compounds, methods of treating tetracycline responsive states, and pharmaceutical compositions containing the 7-substituted fused ring tetracycline compounds are described.

Claims (20)

1. A method for synthesizing 7-iodo sancycline, 7-iodo oxytetracycline, 7-iodo methacycline, 7-iodo doxycycline or 7-iodo tetracycline, comprising:

treating unsubstituted sancycline, unsubstituted oxytetracycline, unsubstituted methacycline, unsubstituted doxycycline or unsubstituted tetracycline, respectively with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid thereby synthesizing 7-iodo sancycline, 7-iodo oxytetracycline, 7-iodo methacycline, 7-iodo doxycycline or 7-iodo tetracycline.

2. The method of claim 1 , wherein the treatment with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid is initially carried out at 0° C.

3. The method of claim 2 , wherein the treatment with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid initially carried out at 0° C. is subsequently warmed to room temperature.

4. The method of claim 3 , further comprising quenching of the reaction.

5. The method of claim 1 , further comprising purifying the resultant 7-iodo sancycline, 7-iodo oxytetracycline, 7-iodo methacycline, 7-iodo doxycycline or 7-iodo tetracycline.

6. The method of claim 1 , wherein 7-iodo sancycline is synthesized by treating unsubstituted sancycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid.

7. The method of claim 1 , wherein 7-iodo oxytetracycline is synthesized by treating unsubstituted oxytetracycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid.

8. The method of claim 1 , wherein 7-iodo methacycline is synthesized by treating unsubstituted methacycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid.

9. The method of claim 1 , wherein 7-iodo doxycycline is synthesized by treating unsubstituted doxycycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid.

10. The method of claim 1 , wherein 7-iodo tetracycline is synthesized by treating unsubstituted tetracycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid.

11. A method for synthesizing 7-iodo sancycline comprising:

treating unsubstituted sancycline with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid, thereby synthesizing 7-iodo sancycline.

12. The method of claim 11 , wherein the treatment with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid is initially carried out at 0° C.

13. The method of claim 12 , wherein the treatment with at least one equivalent of N-iodosuccinimide in trifluoroacetic acid initially carried out at 0° C. is subsequently warmed to room temperature.

14. The method of claim 13 , further comprising quenching of the reaction.

15. The method of claim 14 , further comprising purifying the resultant 7-iodo sancycline.

16. The method of claim 11 , wherein 1.2 equivalents of N-iodosuccinimide in trifluoroacetic acid are used.

17. The method of claim 12 , wherein the treatment is carried out at 0° C. for forty minutes.

18. The method of claim 13 , wherein the treatment is carried out at room temperature for five hours.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2020
From: ISMAIL, MOHAMED Y.
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 052035/0324 →
TERMINATION OF LIEN ON PATENTS Recorded Dec 23, 2014
From: MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034700/0377 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034113/0910 →
SECURITY INTEREST Recorded Mar 14, 2014
From: PARATEK PHARMACEUTICALS, INC.
To: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
Reel/Frame 032448/0001 →
NOTICE Recorded Mar 8, 2013
From: PARATEK PHARMACEUTICALS, INC.
To: MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
Reel/Frame 029940/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2012
From: NELSON, MARK L.; HONEYMAN, LAURA
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 028918/0418 →